Add Yahoo as a preferred source to see more of our stories on Google. At the 2025 American Heart Association (AHA) Scientific Sessions in New Orleans, researchers shared pooled results from three ...
At the 2025 American Heart Association (AHA) Scientific Sessions in New Orleans, investigators from Japan presented results from the SATISFY-JP trial, a phase II study of satralizumab, a targeted anti ...
The addition of polygenic risk scores (PRS) improved the accuracy of the cardiovascular disease (CVD) risk prediction tool PREVENT across all groups studied, across ancestries. Over 3 million people ...
March 8-15 marks Patient Safety Awareness Week. The AHA has several resources including podcasts, videos and reports that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results